HIV-1 Envelope Changes and Drug Resistance
Author Information
Author(s): Laakso Meg M, Lee Fang-Hua, Haggarty Beth, Agrawal Caroline, Nolan Katrina M, Biscone Mark, Romano Josephine, Jordan Andrea P. O, Leslie George J, Meissner Eric G, Su Lishan, Hoxie James A, Doms Robert W
Primary Institution: University of Pennsylvania School of Medicine
Hypothesis
Can truncations in the V3 loop of HIV-1 envelope lead to resistance against coreceptor inhibitors and increased sensitivity to neutralizing antibodies?
Conclusion
The study found that truncating the V3 loop of HIV-1 envelope can result in resistance to CCR5 inhibitors while enhancing sensitivity to neutralizing antibodies.
Supporting Evidence
- Truncation of the V3 loop led to a virus that was highly sensitive to neutralization by human sera.
- The adapted virus could use CCR5 but was resistant to CCR5 inhibitors.
- The study demonstrated that the V3 loop plays a critical role in protecting HIV from neutralization.
Takeaway
Scientists changed a part of the HIV virus to see if it could avoid medicine that stops it from entering cells. They found that the virus could dodge the medicine but became easier to attack with antibodies.
Methodology
The researchers created HIV-1 strains with truncated V3 loops and tested their ability to infect cells and resist neutralization by antibodies.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website